Since the publication of the guidelines for the assessment and management of non alcoholic
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …

How to assess efficacy of interventions. In clinical practice, and particularly among those
who appear to have mild liver disease, it may be sufficient to note changes (normalization) of …

Background The liver has a critical role in the metabolism of glucose and lipids. Chronic
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …

We report the evidence-based Italian Association for the Study of Liver guidelines for the
appropriate diagnosis and management of patients with nonalcoholic fatty liver disease in …

Although the biochemical steps linking insulin resistance with the metabolic syndrome have
not been completely clarified, mounting experimental and clinical evidence indicate …

In the early 1930s, Banting and Best, the discoverers of insulin, found that choline could
prevent the development of fatty liver disease (steatosis) in pancreatectomized dogs treated …

OBJECTIVES: HCV and NAFLD are associated with atherosclerosis in general population.
The prevalence of atherosclerosis in chronic hepatitis C (CHC) patients is unknown. We …

Chronic liver diseases are very common worldwide, particularly those linked to viral hepatitis
and to alcoholic and non-alcoholic fatty liver. Their natural history is variable and long-term …

The hepatic complications of chronic hepatitis C (CHC) usually occur only after progression
to cirrhosis has taken place. Progression to cirrhosis, however, is extremely variable and …

The aim of this paper is to review and up to date the prevalence of hepatitis C virus (HCV)-
associated non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …